A five-month-old baby with a spinal disorder has become the first NHS patient in England to be treated with a potentially life-saving drug that can prolong life.
The baby who's become the first patient in England to get a potentially life-saving drug with a £1.79 million a dose price tag on the NHS.
With a COVID-19 vaccine coming onto the market, the need to revise South Africa’s outdated patent laws has never been greater.
Australia is in the grip of a drug crisis involving prescription medication.
Drug giants could quit the UK unless the NHS gets more funding.